AVICENNA DAYS 2023
Tuesday October 10th: “Uncovering the regulatory pathway”
We are honoured to introduce our prestigious speakers who will share some very interesting case studies:
·“Artificial intelligence-driven drug development against autoimmune diseases", Philippe Moingeon, Head of therapeutic area immuno-inflammation. Application of AI to drug development, Servier
·“Scoping and Validating an In Silico Clinical Trial: A Case Study on a Shoulder Stem", Jeff Bischoff, Senior Research Director (Biomechanics), Zimmer Biomet
·“In Silico Advancements in Cardiovascular Device Design and Approval”, Simon Sonntag, CEO and co-founder, Virtonomy
·"In-silico trial of intracranial flow diverters replicates and expands insights from conventional clinical trials", Professor Alejandro Frangi, University of Manchester
